JP2013523686A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523686A5 JP2013523686A5 JP2013501816A JP2013501816A JP2013523686A5 JP 2013523686 A5 JP2013523686 A5 JP 2013523686A5 JP 2013501816 A JP2013501816 A JP 2013501816A JP 2013501816 A JP2013501816 A JP 2013501816A JP 2013523686 A5 JP2013523686 A5 JP 2013523686A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine according
- polypeptide
- vaccine
- antigen
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10305317 | 2010-03-29 | ||
| EP10305317.9 | 2010-03-29 | ||
| PCT/EP2011/054866 WO2011120994A1 (en) | 2010-03-29 | 2011-03-29 | Pharmaceutical compositions comprising a polypeptide comprising at least one cxxc motif and heterologous antigens and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523686A JP2013523686A (ja) | 2013-06-17 |
| JP2013523686A5 true JP2013523686A5 (https=) | 2014-05-15 |
| JP5942296B2 JP5942296B2 (ja) | 2016-06-29 |
Family
ID=42312972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013501816A Expired - Fee Related JP5942296B2 (ja) | 2010-03-29 | 2011-03-29 | 少なくとも１つのｃｘｘｃモチーフを含むポリペプチドと異種抗原とを含む医薬組成物、及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9801927B2 (https=) |
| EP (2) | EP2552476B1 (https=) |
| JP (1) | JP5942296B2 (https=) |
| KR (1) | KR101866301B1 (https=) |
| CN (1) | CN103002909B (https=) |
| AR (1) | AR081809A1 (https=) |
| BR (1) | BR112012024872B1 (https=) |
| CA (1) | CA2792174C (https=) |
| ES (1) | ES2619077T3 (https=) |
| SG (1) | SG183977A1 (https=) |
| UY (1) | UY33297A (https=) |
| WO (1) | WO2011120994A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2709176T3 (es) | 2006-08-11 | 2019-04-15 | Life Sciences Res Partners Vzw | Péptidos inmunogénicos y su uso en trastornos inmunitarios |
| US9248171B2 (en) * | 2008-02-14 | 2016-02-02 | Imcyse Sa | Immunogenic peptides and their use in transplantation |
| ES2545886T3 (es) | 2008-02-14 | 2015-09-16 | Life Sciences Research Partners Vzw | Inmunoterapia dirigida a patógenos intracelulares |
| EP2252329B1 (en) | 2008-02-14 | 2015-06-17 | Life Sciences Research Partners VZW | Elimination of immune responses to viral vectors |
| EP2247306B1 (en) | 2008-02-14 | 2018-04-18 | Life Sciences Research Partners VZW | Immunogenic control of tumours and tumour cells |
| EP2249864B1 (en) * | 2008-02-14 | 2016-05-04 | Life Sciences Research Partners VZW | Strategies to prevent and/or treat immune responses to soluble allofactors |
| ES2924027T3 (es) | 2010-11-25 | 2022-10-04 | Imcyse Sa | Péptidos inmunogénicos para su uso en la prevención y/o tratamiento de enfermedades infecciosas, enfermedades autoinmunitarias, respuestas inmunitarias a alofactores, enfermedades alérgicas, tumores, rechazo de injerto y respuestas inmunitarias contra vectores virales usados para terapia génica o vacunación génica |
| GB201201511D0 (en) | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
| US9457096B2 (en) | 2012-07-06 | 2016-10-04 | Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Concet) | Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery |
| JP2014212722A (ja) * | 2013-04-24 | 2014-11-17 | 学校法人加計学園 | 八面体構造を有するｂ型肝炎ウイルス様粒子結晶 |
| GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
| GB201418433D0 (en) | 2014-10-17 | 2014-12-03 | Imcyse Sa | Novel immunogenic peptides |
| US10729791B2 (en) * | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
| JP7090335B2 (ja) | 2015-09-25 | 2022-06-24 | イムサイス エスエー | 治療剤に対する免疫応答を除去するための改善された方法及び化合物 |
| AU2017252192C1 (en) | 2016-04-19 | 2023-06-08 | Imcyse Sa | Novel immunogenic CD1d binding peptides |
| EP3592765A1 (en) | 2017-03-09 | 2020-01-15 | ImCyse SA | Peptides and methods for the treatment of diabetes |
| EP4144752A1 (en) * | 2021-09-02 | 2023-03-08 | Sorbonne Universite | Viral-like particles for the treatment or prevention of an infection by a coronaviridae virus |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6165469A (en) * | 1988-01-13 | 2000-12-26 | University Of Virginia | Recombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kD subunit multigene family |
| CA2365196C (en) * | 1999-03-12 | 2011-11-15 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| EP1201750A1 (en) * | 2000-10-26 | 2002-05-02 | Genopoietic | Synthetic viruses and uses thereof |
| NZ537003A (en) | 2002-07-18 | 2008-03-28 | Cytos Biotechnology Ag | Hapten-carrier conjugates comprising virus like particles and uses thereof |
| US7943396B2 (en) * | 2004-06-22 | 2011-05-17 | The Regents Of The University Of California | Peptide-coated nanoparticles with graded shell compositions |
| DE502004010408D1 (de) | 2004-07-02 | 2009-12-31 | Schoelly Fiberoptic Gmbh | Vorrichtung und verwendung der vorrichtung zur aufnahme und verarbeitung eines bildes |
| WO2006026746A2 (en) | 2004-08-31 | 2006-03-09 | The Government Of United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods to separate and expand antigen-specific t cells |
| GB0426641D0 (en) * | 2004-12-03 | 2005-01-05 | Bioactive Protein Delivery The | Protein delivery system |
| DK2029120T3 (da) | 2006-04-13 | 2011-10-31 | Midatech Ltd | Nanopartikler indeholdende tre forskellige ligander til tilvejebringelse af immunresponser mod smitstoffer |
| US9439959B2 (en) * | 2006-07-27 | 2016-09-13 | Takeda Vaccines, Inc. | Chimeric influenza virus-like particles |
| ES2709176T3 (es) * | 2006-08-11 | 2019-04-15 | Life Sciences Res Partners Vzw | Péptidos inmunogénicos y su uso en trastornos inmunitarios |
| EP2199301A1 (en) * | 2008-12-19 | 2010-06-23 | DKFZ Deutsches Krebsforschungszentrum | Immunogenic polypeptides comprising a scaffold polypeptide and a L2 polypeptide or fragment thereof |
-
2011
- 2011-03-29 CN CN201180017201.7A patent/CN103002909B/zh not_active Expired - Fee Related
- 2011-03-29 BR BR112012024872-3A patent/BR112012024872B1/pt active IP Right Grant
- 2011-03-29 EP EP11710794.6A patent/EP2552476B1/en active Active
- 2011-03-29 CA CA2792174A patent/CA2792174C/en active Active
- 2011-03-29 KR KR1020127028358A patent/KR101866301B1/ko not_active Expired - Fee Related
- 2011-03-29 AR ARP110101036A patent/AR081809A1/es not_active Application Discontinuation
- 2011-03-29 JP JP2013501816A patent/JP5942296B2/ja not_active Expired - Fee Related
- 2011-03-29 US US13/636,482 patent/US9801927B2/en active Active
- 2011-03-29 EP EP16002285.1A patent/EP3156068B1/en active Active
- 2011-03-29 SG SG2012066791A patent/SG183977A1/en unknown
- 2011-03-29 UY UY0001033297A patent/UY33297A/es active IP Right Grant
- 2011-03-29 ES ES11710794.6T patent/ES2619077T3/es active Active
- 2011-03-29 WO PCT/EP2011/054866 patent/WO2011120994A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523686A5 (https=) | ||
| Medhi et al. | Nanoparticle-based strategies to combat COVID-19 | |
| Gupta et al. | Platforms, advances, and technical challenges in virus-like particles-based vaccines | |
| Huang et al. | Escherichia coli-derived virus-like particles in vaccine development | |
| Rockman et al. | New technologies for influenza vaccines | |
| US12472244B2 (en) | Immunogenic compositions and uses thereof | |
| SG131116A1 (en) | Functional influenza virus-like particles (vlps) | |
| EP2361930A3 (en) | Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases | |
| JP2016519933A5 (https=) | ||
| EP4609876A3 (en) | Anti-human papillomavirus 16 e7 t cell receptors | |
| JP2010011868A5 (https=) | ||
| JP2019513005A5 (https=) | ||
| JP2018532382A5 (https=) | ||
| JP2013521789A5 (https=) | ||
| WO2007095320A3 (en) | Hpv antigens, vaccine compositions, and related methods | |
| CN106008716A (zh) | 呼吸道合胞病毒抗原组合物和方法 | |
| WO2009055491A3 (en) | Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres | |
| JP2016539641A5 (https=) | ||
| Alhashimi et al. | Nonhuman adenoviral vector-based platforms and their utility in designing next generation of vaccines for infectious diseases | |
| Gandhapudi et al. | Recombinant protein vaccines formulated with enantio-specific cationic lipid R-DOTAP induce protective cellular and antibody-mediated immune responses in mice | |
| JP2010538619A5 (https=) | ||
| Tortellini et al. | Immunogenicity and efficacy of vaccination in people living with human immunodeficiency virus | |
| EP3819306A3 (en) | Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes | |
| JP2008539228A5 (https=) | ||
| Zhuang et al. | Harnessing T-cells for enhanced vaccine development against viral infections |